chr1 Antibody

Mechanism of Folding and Quality Control

The CH1 domain’s folding is tightly regulated in the endoplasmic reticulum (ER):

• Association-coupled folding: CH1 gains structure only upon binding to CL, forming a hydrophobic cluster (e.g., Val21, Trp73) .

• Chaperone interplay: BiP binds partially folded CH1, preventing premature secretion. Cyclophilin B accelerates proline isomerization, a rate-limiting step in folding .

• Disulfide bond dependency: Proper folding requires an intact internal disulfide bridge (Cys22–Cys96 in murine IgG1) .

Functional Impact on Antibody Assembly

• ER retention: Free heavy chains are retained in the ER via CH1-BiP interactions until light chain binding displaces BiP .

• Secretion control: Deletion or mutation of CH1 allows secretion of heavy chains alone, bypassing normal quality control .

• Class-specific stability: CH1γ (IgG) folds more efficiently than CH1μ (IgM), enabling higher BCR expression and antigen responsiveness .

Antigen Sensing and Immune Response

Studies on IgG1 vs. IgM BCRs (B cell receptors) reveal CH1’s role in antigen detection:

• IgG1-BCR: Higher stability allows recognition of multimeric antigens (e.g., HIV gp140 tetramers) .

• IgM-BCR: Lower CH1 stability limits responses to high-affinity monomers (e.g., HIV eODGT8) .

Clinical and Biotechnological Relevance

• Antibody engineering: Stabilizing CH1γ improves expression of antibodies with unstable variable domains (e.g., HIV broadly neutralizing antibodies) .

• Disease mechanisms: Misfolded CH1 domains contribute to heavy chain deposition diseases .

• Characterization challenges: CH1’s unstructured state complicates antibody validation, necessitating advanced methods like KO cell lines and orthogonal assays .

Key Research Findings

• Intrinsic disorder: NMR and fluorescence quenching confirm CH1’s unfolded state in isolation .

• Chimeric antibodies: Replacing CH1μ with CH1γ in IgM enhances secretion and antigen responses, mimicking IgG functionality .

• Evolutionary adaptation: CH1γ’s stability counterbalances somatic hypermutation in IgG antibodies .